FDA Clearance Tracker · P150038-S009
Exablate Model 4000 System
Last checked: Nov 20, 2026Latest source record: Jun 28, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jun 28, 2019
Approved
Time to decision
193 days
Received Dec 17, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
Device type
- Device type
- MR-guided focused ultrasound system (POH)
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
Approval for the Exablate 4000 Type 1.1 System SW Version 7.3 to support the operation of the Type 1.1 System SW version 7.2 and to include compatibility with the GE Premier Magnetic Resonance (MR) System.
Source documents
Other decisions for Insightec
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Exablate Model 4000 Type-1 SystemPMA supplement
P150038-S037 · Decided Jul 3, 2025 · 352 days after receipt · Panel Track
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.